Phase III multi-centre, randomised, placebo-controlled study to evaluate the safety & efficacy of subcutaneous bioresorbable CUV1647 implants in patients with erythropoietic protoporphyria.

Project Details

Short titleR:KAE RHOL9
StatusFinished
Effective start/end date1/12/0730/10/10

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.